Cigna raises 2026 adjusted EPS guidance to at least $30.60
CI•Cigna raised its 2026 adjusted EPS guidance by $0.15 to at least $30.60 after third-quarter adjusted EPS of $7.98 exceeded expectations. It also increased healthcare pre-tax adjusted operating income guidance by $50 million to at least $4.6 billion.
1. Raised 2026 outlook
Cigna raised its 2026 adjusted EPS guidance by $0.15 to at least $30.60, following third-quarter adjusted EPS of $7.98 that exceeded expectations. Healthcare pre-tax adjusted operating income guidance rose $50 million to at least $4.6 billion, while Evernorth’s forecast remained at least $6.9 billion.
2. Other forecasts
Cigna narrowed its medical care ratio forecast to 84.2%, plus or minus 25 basis points, from a range of 83.7% to 84.7%. For 2027, it continues to project adjusted EPS growth of at least 10% above an ongoing-business run-rate baseline of at least $30.
3. Expected growth drivers
Cigna cited improved stop-loss margins, strong sales and productivity gains as expected growth drivers, partly offset by its ACA exchange exit and pharmacy pressures.
